Depot Selection and Management Strategy

Determining the best global supply strategy based upon the study design can be a complex discussion involving a number of variables depending upon the study design.

Depot Selection and Management Strategy

As global regulations change, an in-country depot solution versus direct to site shipments from a CMO can greatly impact the success and budget of a trial.

Strategy considerations:

  • Depot oversight including audit requirements (Global Quality Management Systems)
  • Import licence type/requirements and associated timelines
  • Order strategy (including IRT look ahead period / patient dosing)
  • Depot capabilities (S&D, JIT labelling, Returns and Destruction)
  • Stability of product being shipped
  • In country infrastructure

To listen to the audio recording from this Water Cooler Chat, please complete the form below

Our dedicated team of specialists will be happy to discuss any of your supply strategy questions or concerns. Contact us on +1 779-208-1819 (US) or +44 1495 711 222 (UK/EU) or email talkfuture@pci.com

When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?

Your bridge between life-changing therapies and patients